Journal
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
Volume 12, Issue 6, Pages 680-686Publisher
SPRINGER
DOI: 10.1007/s11910-012-0313-4
Keywords
Progressive multifocal leukoencephalopathy; JC virus; Natalizumab; Rituximab; Efalizumab; Monoclonal antibodies
Categories
Ask authors/readers for more resources
Progressive multifocal leukoencephalopathy (PML) is a severe, often fatal, opportunistic viral infection of the central nervous system that is mainly seen in the context of AIDS and certain monoclonal immune-suppressive therapies. The causative agent, a polyoma virus, named JC virus infects only humans and there is no animal model for PML. This update focuses on information gathered in recent years on the pathogenesis of the disorder, on several clinical aspects associated with diagnosis and therapy, and on the immune reconstitution inflammatory syndrome (IRIS), a complication associated with removal of immunosuppressive therapy in PML.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available